Vascudyne’s New Organic Material to Replace Artificial Tissue for Heart Surgery
The U of M startup has developed living tissue for safer cardiovascular sugery.
Licensed from the University of Minnesota, the Vascudyne bioengineered tissue is manufactured from cells that create a robust decellularised collagen substrate—the protein found in skin and other connective tissues.
The organic material, which has similar properties to the tissue found in a human body, can be fully integrated with the rest of the heart and grow within the body—as well as able to heal itself—resulting in safer cardiovascular surgery.
This story was originally posted in Compelo but is no longer available.